All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

An analysis of TRITON-TIMI 38, based on the 12 month recommended length of therapy in the European label for prasugrel

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F14%3A43909178" target="_blank" >RIV/00216208:11120/14:43909178 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064173:_____/14:N0000004

  • Result on the web

    <a href="http://dx.doi.org/10.1185/03007995.2014.944638" target="_blank" >http://dx.doi.org/10.1185/03007995.2014.944638</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1185/03007995.2014.944638" target="_blank" >10.1185/03007995.2014.944638</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    An analysis of TRITON-TIMI 38, based on the 12 month recommended length of therapy in the European label for prasugrel

  • Original language description

    In TRITON-TIMI 38, patients with acute coronary syndromes were treated with prasugrel or clopidogrel, with aspirin, for a median of 14.5 (maximum of 15) months. Based on this trial, the EU label for prasugrel recommends treatment for up to 12 months andexcludes patients with prior stroke/transient ischemic attack (TIA). Furthermore, the EU label recommends the 10 mg maintenance dose (MD) for patients with body weight >=60 kg and age <75 years. A lower MD of 5 mg is recommended for those with body weight <60 kg; although generally not recommended, 5 mg can be prescribed to patients >=75 years after individual risk-benefit evaluation. This paper presents the one-year outcome data for this 10 mg indicated cohort. METHODS AND RESULTS: From the overall cohort of 13,608 patients in TRITON-TIMI 38, 10,804 fulfilled inclusion criteria for the 10 mg indicated cohort, of whom 22% had a history of diabetes, 73% an index diagnosis of unstable angina/non-ST-segment-elevation myocardial infarction

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FA - Cardiovascular diseases including cardio-surgery

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Current Medical Research and Opinion

  • ISSN

    0300-7995

  • e-ISSN

  • Volume of the periodical

    30

  • Issue of the periodical within the volume

    11

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    13

  • Pages from-to

    2193-2205

  • UT code for WoS article

    000344606300006

  • EID of the result in the Scopus database